All news (page 7)

• 

  13 May 2026

  Trinseo launches VOLTABOND 211 SBR binder for fast-charging batteries

  A new water‑based SBR anode binder for graphite/silicon minimizes binder migration, lowers surface resistivity ~5% and whole‑cell DCIR up to 18%, while retaining adhesion and heat resistance.
• 

  13 May 2026

  Perpetual Next selects Clarksons to broker maritime biomethanol

  Chosen broker will market scalable, waste-to-biomethanol via international offtake, finance and logistics for maritime bunkering as demand rises with decarbonization rules.
• 

  13 May 2026

  TotalEnergies, EGAS sign Egypt offshore exploration MoU

  Agreement to assess a large area in Egypt's north-west offshore, setting technical cooperation for preliminary exploration and subsurface evaluation of deep offshore potential.
• 

  13 May 2026

  Novo Nordisk: Wegovy pill yields 21.6% weight loss in early responders and doubles mobility improvement

  Nearly 29% were early responders (≥10% by 16w), averaging 13.2% loss at 16w; non-responders still lost 11.5% by wk64. Overall mean 17% vs 2.7% placebo. Outperformed orforglipron; GI AEs mostly mild.
• 

  13 May 2026

  bp takes 40% stake in North Ustyurt PSA, Uzbekistan

  40% stake acquired in North Ustyurt PSA; remaining interests split 30%/30% with operator holding 30%. PSA covers six blocks; seismic exploration started after signing in Tashkent.
• 

  13 May 2026

  bp joins Ustyurt PSA with 40% stake

  At OGU 2026, accession documents signed for the Ustyurt PSA covering Boyterak, Terengquduq, Birqori, Kharoy, Qoraqalpoq and Qulboy. Project at early stage; operator conducting seismic surveys.

• 

  12 May 2026

  Messer Belgium builds sustainable air separation plant at North Sea Port

  €60M investment creates 30 jobs to produce oxygen, nitrogen and argon; construction starts mid‑May, commissioning by 2028, CO2‑free operation using green electricity; serves Lille‑Rotterdam axis
• 

  12 May 2026

  Lilly: Foundayo and reduced-dose Zepbound maintain weight loss after switching from high-dose injectables

  Two late-phase trials: switching from high-dose injectable incretins to an oral GLP-1 or reducing injectable dose preserved most prior weight loss at 1 year; safety matched prior Phase 3
• 

  12 May 2026

  TotalEnergies signs MoU with Syrian Petroleum Company for Block 3 offshore exploration

  MoU creates a framework for technical review and commercial discussions to assess exploration of offshore Block 3 in Syria's Mediterranean.
• 

  12 May 2026

  Boehringer Ingelheim licenses Immunitas preclinical antibody program for chronic inflammatory diseases

  Global license of a preclinical antibody that targets pathogenic cells at inflammation sites to provide durable control in chronic immune diseases; includes milestones to €407.5M +royalties
• 

  12 May 2026

  Novo Nordisk: Wegovy cuts weight and reduces cardiovascular and migraine risk across menopausal stages

  Trials and real‑world data: semaglutide gave 19.7–22.6% weight loss, 15–17.5% waist reduction, ~42% MACE risk reduction in perimenopause, 42–45% lower migraine and 25% lower depression risk
• 

  12 May 2026

  ABO Energy achieves restructuring milestones and defines strategic priorities

  Restructuring draft finds firm viable; sets strategic action areas. Targets sustainable financing by end-July. Won 7.8 MW solar tariff, bid >150 MW wind, sold 16.8 MW farm and 4.5 MW turbine.
• 

  12 May 2026

  Eni and MSC Cruises test Enilive HVO diesel on cruise ship

  Pure HVO ran ~2,000 hours on a ship engine with no modifications; matched fuel performance, cut NOx ~16% and particulates, and cut lifecycle GHG ~80%. Validated by maker and independent certifier.
• 

  12 May 2026

  Coolbrook appoints Dr Frank Eulitz CTO to lead industrial scale-up

  Veteran turbomachinery expert brings 30+ years' R&D and OEM experience to lead scale-up and manufacturing of RotoDynamic electrification tech for high-temperature, fossil-free industrial heat
• 

  12 May 2026

  Iberdrola grows Italy renewable capacity to 450 MW with 40 MW Basilicata wind acquisition

  Commissioned in 2018, the plant has long‑term incentives ensuring stable cash flows. Near Lucania Complex, it complements Montelungo (20 MW), Etruria and Fenix (243 MW).
• 

  12 May 2026

  Novo Nordisk: Wegovy 7.2 mg yields ~28% weight loss in early responders

  STEP UP trial: early responders (≥15% at 24w) sustained major weight loss at 72w; higher dose reached goals faster than 2.4 mg; 84% of lost weight was fat and muscle function preserved.
• 

  12 May 2026

  Uniper posts Q1 2026 results, reaffirms 2026 earnings guidance

  Q1 adjusted EBITDA €407m, adjusted net income €231m; operating cash flow €1,588m; net cash €4,394m. Segments: Green €250m, Flexible €156m, Greener Commodities €66m. Stable amid market volatility.
• 

  12 May 2026

  DOMO Engineered Materials joins RadiciGroup to create global tier‑1 compounder

  Acquisition closed; combined global tier‑1 compounding platform serving diverse end markets. TECHNYL brand and teams remain; CEO appointed; focus on innovation and sustainability.
• 

  12 May 2026

  EWE awards Bilfinger contract for Emden hydrogen plant

  Final major contract fixes cost and planning for a 320 MW electrolyser, enabling long-term green-hydrogen supply deals. First production slated late 2027; stable regulation needed.
• 

  12 May 2026

  Asahi Kasei to Realign Material Supply by FY2030

  Streamline Mizushima Works by FY2030; no immediate supply impact. Exiting low-margin derivative businesses (¥116.2bn 2025) to boost margins, free capital for pharma, healthcare, homes, electronics.
• 

  12 May 2026

  PETRONAS LNG signs 20-year charter with MISC for five LNG carriers

  174,000-cbm newbuild LNG vessels to be built in Shanghai, delivery 2029–2030; will use XDF2.1 propulsion, shaft generators and onboard reliquefaction; project and ship management arranged.
• 

  12 May 2026

  Asahi Kasei, Mitsui Chemicals and Mitsubishi Chemical agree 45/45/10 equity split for western Japan ethylene JV

  Plan to integrate western Japan ethylene assets: close Mizushima plant by 2030 and consolidate operations at a single site to decarbonize, optimize capacity and strengthen competitiveness.
• 

  11 May 2026

  PTT Global Chemical Tops S&P Global Sustainability Ranking for 7th Year

  Ranked Top 1% in S&P Global CSA for seven consecutive years; the first company to do so. Named Sustainability Yearbook Member 13 years and added to Dow Jones Best‑in‑Class World and Emerging indices.
• 

  11 May 2026

  Worley partners with Baker Hughes to deliver integrated LNG solutions

  Non-exclusive MOU to jointly develop integrated, lower-carbon LNG projects - combining EPCM/EPCI delivery, modular liquefaction, advanced turbomachinery and digital tools to derisk and speed delivery
• 

  11 May 2026

  Covestro to install Dormagen steam compressor, cutting Germany energy use 2%

  Heat-pump upgrade will save ~40,000 t CO2/yr, cut low three-digit GWh energy use; investment low double-digit million euros; expected operation mid-2027.
• 

  11 May 2026

  LanzaTech selects North Sea Port, Ghent for Europe’s first commercial ATJ SAF plant

  €500M ATJ project targeting 79,000 t/yr SAF and 9,000 t/yr renewable diesel; EIA scoping filed; ~50 permanent jobs and ~300 FTE construction; FEED complete; EU Horizon support.
• 

  11 May 2026

  BASF Agricultural Solutions opens BioHub fermentation plant in Ludwigshafen

  High double‑digit €m investment started commercial fermentation of biological crop actives (B. amyloliquefaciens, P. coprobium), boosting production flexibility and supply resilience.
• 

  11 May 2026

  RIFT expands Iron Fuel plans to Rotterdam

  Reserved Maasvlakte with Port of Rotterdam to advance commercial-scale Iron Fuel projects; Rotterdam complements Antwerp with infrastructure, logistics and low-carbon hydrogen
• 

  11 May 2026

  Ørsted and PGE start Baltica 2 offshore installation

  First foundations installed for a 1.5 GW offshore wind farm. 111 monopiles (107 turbine, 4 substation) to be installed through Q4 2026; commissioning expected in 2027; 25-yr CfD.
• 

  11 May 2026

  GSK partners with Sino Biopharmaceutical (CTTQ) for exclusive China launch of bepirovirsen

  Potential first-in-class CHB treatment under priority review in China; deal provides access to 5,000+ medical centres at launch, local import/distribution, hospital access and initial 5.5-yr supply.